These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


460 related items for PubMed ID: 12581683

  • 1. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
    Opitz CF, Wensel R, Bettmann M, Schaffarczyk R, Linscheid M, Hetzer R, Ewert R.
    Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
    [Abstract] [Full Text] [Related]

  • 2. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
    Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W.
    Ann Intern Med; 1996 May 01; 124(9):820-4. PubMed ID: 8610951
    [Abstract] [Full Text] [Related]

  • 3. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbrück B, Grimminger F, Seeger W.
    Pneumologie; 2000 Mar 01; 54(3):133-42. PubMed ID: 10783653
    [Abstract] [Full Text] [Related]

  • 4. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
    Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbruck B, Grimminger F, Seeger W.
    Am J Respir Crit Care Med; 1999 Aug 01; 160(2):600-7. PubMed ID: 10430735
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
    Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, Niedermeyer J, Fabel H, Seeger W.
    J Am Coll Cardiol; 2000 Jan 01; 35(1):176-82. PubMed ID: 10636277
    [Abstract] [Full Text] [Related]

  • 6. Long-term treatment of pulmonary hypertension with aerosolized iloprost.
    Machherndl S, Kneussl M, Baumgartner H, Schneider B, Petkov V, Schenk P, Lang IM.
    Eur Respir J; 2001 Jan 01; 17(1):8-13. PubMed ID: 11307761
    [Abstract] [Full Text] [Related]

  • 7. Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost.
    Olschewski H, Ghofrani HA, Walmrath D, Temmesfeld-Wollbrück B, Grimminger F, Seeger W.
    Intensive Care Med; 1998 Jun 01; 24(6):631-4. PubMed ID: 9681789
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
    Tian Z, Chen TB, Fang Q, Zeng XF, Liu YT, Li MT, Jiang XC, Gao P, Cheng KA, Wang Q.
    Zhonghua Yi Xue Za Zhi; 2009 Aug 11; 89(30):2099-102. PubMed ID: 20058611
    [Abstract] [Full Text] [Related]

  • 10. Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension.
    Schenk P, Petkov V, Madl C, Kramer L, Kneussl M, Ziesche R, Lang I.
    Chest; 2001 Jan 11; 119(1):296-300. PubMed ID: 11157622
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
    Sablotzki A, Hentschel T, Gruenig E, Schubert S, Friedrich I, Mühling J, Dehne MG, Czeslick E.
    Eur J Cardiothorac Surg; 2002 Nov 11; 22(5):746-52. PubMed ID: 12414041
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise.
    Blumberg FC, Riegger GA, Pfeifer M.
    Chest; 2002 May 11; 121(5):1566-71. PubMed ID: 12006445
    [Abstract] [Full Text] [Related]

  • 15. The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension.
    Scott JP, Higenbottam T, Wallwork J.
    Br J Clin Pract; 1990 Jun 11; 44(6):231-4. PubMed ID: 1698429
    [Abstract] [Full Text] [Related]

  • 16. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N, Lundin S, Ricksten SE.
    J Heart Lung Transplant; 1995 Jun 11; 14(3):436-43. PubMed ID: 7654728
    [Abstract] [Full Text] [Related]

  • 17. Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension.
    Gessler T, Schmehl T, Hoeper MM, Rose F, Ghofrani HA, Olschewski H, Grimminger F, Seeger W.
    Eur Respir J; 2001 Jan 11; 17(1):14-9. PubMed ID: 11307743
    [Abstract] [Full Text] [Related]

  • 18. [The acute effects of inhaled iloprost on hemodynamics and oxygenation in chronic thromboembolic pulmonary hypertension].
    Luo L, Yang YH, Cui N, Xie WM, Zhai ZG, Ma ZH, Wang C.
    Zhonghua Yi Xue Za Zhi; 2009 Aug 11; 89(30):2103-5. PubMed ID: 20058612
    [Abstract] [Full Text] [Related]

  • 19. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost.
    Higenbottam TW, Butt AY, Dinh-Xaun AT, Takao M, Cremona G, Akamine S.
    Heart; 1998 Feb 11; 79(2):175-9. PubMed ID: 9538312
    [Abstract] [Full Text] [Related]

  • 20. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
    Kramm T, Eberle B, Guth S, Mayer E.
    Eur J Cardiothorac Surg; 2005 Dec 11; 28(6):882-8. PubMed ID: 16242948
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.